In samples treated with MHA-PFO plasma aspirin showed a trend toward a small reduction in TF and ROS expression and MV release, whereas these parameters were significantly inhibited by the P2Y 12 antagonist.
← all excerpts
Migraine in Patients Undergoing PFO Closure: Characterization of a Platelet-Associated Pathophysiological Mechanism: The LEARNER Study.
1
—
—